Drugs A-Z Is my price fair? Price changes Drug markups Drug shortages Recalls Medicare prices Upcoming generics What people paid Guides Share what you paid
Theme
Class ITerminatedD-1059-2019

Drug recall · March 20, 2019

Levoleucovorin Injection recall

Why: Presence of Particulate Matter: particulate matter identified as copper salts

Class I: a reasonable chance the product could cause serious harm or death.

The recall

Product

Levoleucovorin Injection, 250 mg/25 mL, (10 mg/mL), 25 mL Single-Use Vial, Rx only, Manufactured for: Mylan Institutional LLC, Rockford, IL 61103 U.S.A., Made in India. NDC: 67457-601-30

Lots / codes

Lot #: APB032, APB033, Exp. April 2019

Quantity
11,964 cartons of 30 vials
Company
Mylan Institutional Inc, Rockford, IL
Distribution
Nationwide in the United States
Initiated
February 1, 2019 · Voluntary: Firm initiated
Classified
March 26, 2019
Reported
March 20, 2019
Ended
June 19, 2020
How notified
Letter

The drug: prices, other makers, shortages

If you have this product

  1. Check the lot number on your package against the lots above. Only those lots are recalled.
  2. Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
  3. Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
  4. Return or dispose of recalled product as the company or your pharmacy advises.

Questions about this recall

Be kind and stay on topic. No personal health details, links or selling. This is not medical advice.

No comments yet. Questions, tips, what worked for you - start the conversation.

Watch Levoleucovorin

One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.

Help the next person

Know what your pharmacy pays.

Every price you share shows someone else what's fair - and which pharmacies charge the least. It takes 30 seconds and it's anonymous.